INTRODUCTION
Human factors engineering has been repeatedly proposed, but largely untested, as the key to improving patient safety. The value of this approach was investigated in the context of a commercially available patient-controlled analgesia device that has been linked with several alleged patient injuries and deaths. Several reports have stated that Adverse drug events are the single leading cause of medierrors in programming drug concentration were made during these cal injuries, accounting for 19.4% of all adverse events idenadverse drug events. A simulation of the commercially available intertified in the landmark Harvard Medical Practice Study [1] .
face was compared experimentally with a simulated prototype of a new Preventable adverse drug events lead to extended hospital interface designed according to a human factors process. Professional nurses, averaging over 5 years of clinical experience with the commerstays that have been estimated to cost $2 billion annually cially available interface and only minimal experience with the new in the United States, not including costs of injuries to patients interface, programmed both interfaces. The new interface eliminated or malpractice costs [2] . In the follow-up Harvard Adverse drug concentration errors, whereas the simulated commercially availDrug Event Study, analgesics (e.g., morphine, meperidine) able interface did not. Also, the new interface led to significantly fewer were the most likely drugs to be associated with preventable total errors and faster performance. These findings may have broad implications for the design, regulation, and procurement of biomedical medical injury [3] . Furthermore, 45% of the adverse drug devices, products, or systems that improve patient safety in clinical events associated with analgesics involved misuse or malsettings. ᭧ 2001 Elsevier Science (USA) analgesia (PCA) infusion pumps satisfies this criterion, and pump was chosen. This device is used daily at our local teaching hospitals. Anecdotal reports from nurses indicated thus is a suitable choice for research on patient safety.
that the device was difficult to program, and thus could perhaps benefit from being redesigned. The LifeCare 4100
Patient-Controlled Analgesia
PCA pump is the market leader, has been used on over 22 Traditionally, analgesia was only delivered in large, infremillion patients, and "represents approximately 75% of all quent doses by a nurse who had to retrieve, prepare, and PCA use in the U.S." [7] . The device is also used around administer the drug manually. This process can be ineffective the world, and in nearly 4000 hospitals in the United States because patients may become oversedated by large doses, alone [8] . These figures suggest that the LifeCare 4100 is and inefficient because nurses must perform several timefrequently and widely used, making it a suitable choice for consuming steps. PCA pumps have the potential to improve research on PCA infusion pumps. pain management for patients and reduce workload for nurses by using automation technology to help patients selfadminister more frequent, but smaller doses of analgesiaAdverse Drug Event Reports with LifeCare 4100 usually morphine [4, 5] . For most patients, the PCA device is easy to use. Whenever they are in pain, or are about to After the experiment described below was completed, we do something likely to be painful (e.g., get out of bed), learned that several patients had allegedly died or been inpatients press a push-button on a pendant. If the patient is jured while connected to the LifeCare 4100 [9] [10] [11] [12] [13] [14] . The eligible to get a dose (as determined by the computer proincidence of such adverse drug event reports appears to be gram in the pump), a dose of analgesic is pumped into an low [7] . However, it is well known that adverse events in intravenous line by an automatic controller. If insufficient general, and adverse drug events in particular, are both vastly time has elapsed since the last dose (the "lockout period"), underreported. Epidemiological studies have observed rethe program denies the patient's request.
porting rates ranging from a low of 1.2% to a high of 7.7% To make sure that patients do not receive too much analge- [15] [16] [17] [18] . Using these estimates, for every adverse drug event sic, a nurse is required to program the PCA pump using that is reported, there are an additional 12 to 82 that go a human-computer interface consisting of displays and a unreported. "This suggests that using [incident reports] as keypad. First, the nurse manually inserts a drug vial into a primary data source to study drug-related complications the machine. Then, the nurse programs several parameters, will be misleading" [15] . including: the concentration of the drug in the vial, the From a human factors engineering point of view, an imdosage that should be given to the patient upon each request, portant question is whether the risk of patient injury or death the lockout interval specifying the minimum time between can be further reduced systematically [19] . To answer this doses, and sometimes, the maximum allowable dose over question, it is important to know if the aforementioned alany 4-h period. The parameters that are entered by the nurse leged patient injuries and deaths occurred under similar cirgovern the behavior of the PCA pump (the patient is not cumstances. Reports of these adverse drug events have reallowed to change the programmed parameters for safety peatedly stated that errors were made in programming drug reasons). There is no way for the pump to verify indepenconcentration [9] [10] [11] [12] [13] [14] . The relationship between drug condently if the settings are correct because it cannot sense the centration errors and patient safety is counterintuitive beconcentration nor the type of analgesic in the vial. Thus, a cause setting the drug concentration at a lower level than programming error could lead to an underdelivery or overdeintended can result in repeated overdeliveries of analgesic livery of analgesic. An overdelivery can, in turn, lead to [5] . For example, if the vial concentration is set to 1.0 mg/ patient injury or death. According to one review of Food mL and a dosage of 1.0 mg of morphine is requested, then and Drug Administration medical device reports 67% of all the pump will infuse 1 mL of liquid (1.0 mg [desired mass problems associated with PCA pumps are attributable to of morphine] Ϭ 1.0 mg/mL [programmed mass of morphine user error, including programming errors [6] .
per beginning; and when the 4-h safety limit should be invoked. Thus,
• Field observations to understand the actual conditions entering a lower than intended drug concentration once can under which users work with technology; result in up to four enduring effects: (a) an overdelivery of
• Task analysis to identify the job demands and perforevery subsequent bolus dose, (b) an overdelivery of every mance bottlenecks faced by users; subsequent PCA dose, (c) an overdelivery of the amount of
• The use of human factors design guidelines (see below continuously delivered analgesic, and (d) an increase in the for examples) to ensure that technology is compatible with amount of analgesic that the device will allow to be infused human capabilities and limitations; during a 4-h period. Any one of these effects alone can pose
• An iterative design process that leverages user feedback a threat to patient safety, but the last effect is particularly to improve initial design concepts; important because it relaxes one of the design features that
• Experimental evaluations of detailed design prototypes PCA pumps have to safeguard patient safety [11] .
with representative users based on objective measures of Note that the counterintuitive relationship between drug performance, not just subjective opinion; concentration errors and patient safety reflects the physics
• Post-market surveillance (e.g., review of adverse event of analgesic delivery. Thus, it holds for any PCA pump, reports) to identify unanticipated threats to safety that can not just the LifeCare 4100 (although some pump interface be removed or reduced by redesign. designs may be more likely to induce this type of error than others). In sum, the key implication from the adverse drug Given the success obtained in other safety-critical indusevent reports is that minimizing the incidence of drug contries, medical researchers have often noted that a comprehencentration errors is particularly critical to ensuring patient sive human factors engineering process may be the key to safety with PCA pumps. Can this class of errors be reduced improving patient safety [22] [23] [24] [25] . However, direct empirical by device redesign?
evidence of the potential benefits of applying human factors The design of the interface has been consistently cited as to medicine is still relatively scant. The primary aim of this a contributing factor in adverse drug event reports with the article is to investigate whether PCA pump interfaces could LifeCare 4100 [9] [10] [11] [12] [13] [14] . For example, the Emergency Care be made less error-prone by redesigning them using a human Research Institute stated: "the likelihood of this sort of misfactors engineering approach. programming is increased by the fact that the user interface and programming logic of the pump are particularly complex and tedious. We believe that the likelihood of user error is Previous Research increased by the repetitive and time-consuming programming process required by this pump" [11] . Thus, the LifeBefore learning of any adverse drug event reports, Lin and colleagues had already redesigned the commercially Care 4100 interface can be used as an experimental testbed to see if the application of human factors engineering techavailable interface for the LifeCare 4100, depicted in Fig.  1a , using human factors engineering techniques [26] . First, niques can make PCA pumps even less prone to error, particularly to drug concentration errors.
comments were obtained from recovery room nurses who had extensive experience with the device, field observations were conducted in the postsurgical recovery room at a teaching hospital, and a task analysis was conducted using bench Human Factors Engineering tests. These activities identified information requirements that could serve as a basis for a device redesign. Other safety-critical industries, such as nuclear power and aviation, have reduced human error by applying techniques Second, the commercially available interface was analyzed using some of the most basic design principles of from human factors engineering [20] . This discipline focuses on the interaction between technology, people, and their human factors engineering:
Old interface for LifeCare 4100, a simulation of the commercially available design. (b) New prototype interface for LifeCare 4100. Copyright 1997 by Laura Lin [27] . All rights reserved.
• Provide users with prompt, salient feedback after commercially available design that could be improved. The each action;
LifeCare 4100 can be operated in three different modes: • Make the functions of the various controls clear and PCA, Continuous, and PCA ϩ Continuous (see below for obvious; a description of each). In the commercially available inter-• Make the displayed messages easy to understand; face, the programming sequence presents these options one • Minimize the load on the users' memory; at a time. At each step, nurses can either accept the currently • Provide users with reliable shortcuts to increase displayed option and set the mode, or they can reject that efficiency; option and go on to the next one. Lin et al. observed that • Provide clearly marked exits for the user to leave the the three modes are not independent; they are three alternasystem. tive ways of operating the device. By presenting the three options serially, the commercially available design may be This analysis identified several aspects of the commermore complex than it needs to be, requiring users to make cially available interface that could perhaps be improved up to three decisions to select the device mode. Accordingly, (e.g., complex dialogue structure, limited feedback, inconsisLin et al. used the principle of "Provide users with reliable tent control functionality, confusing layout of controls, and shortcuts to increase efficiency" to redesign the interface. confusing message displays).
In the New interface, related options are presented in parallel Third, Lin et al. redesigned the interface for the LifeCare wherever possible, so that only one decision is required to 4100 using human factors design principles and the informachoose among the available related alternatives. Consetion requirements they had identified [26] . The result was quently, the programming sequence of the New interface a New prototype interface, shown in Fig. 1b , that has essenappears simpler than that of the Old, as illustrated in Fig.  tially the same functionality as the commercially available 2. (Detailed descriptions of each step in these thumbnail interface, but includes several design changes, such as fewer sketches are provided by Lin [27] .) programming steps, an overview display showing the user's A second example of how human factors was used to location in the programming sequence, more display feedidentify opportunities for redesign involves the setting of back, a more logical layout of controls, and clearer wording drug concentration. In the factory-set configuration (see befor labels and messages. low), the LifeCare 4100 sequentially offers four default opTwo concrete examples can be used to illustrate how a human factors approach helped to uncover aspects of the tions for programming drug concentration (i.e., morphine 1 mg/mL, morphine 5 mg/mL, morphine 0.5 mg/mL, and
The individual findings reviewed thus far have each been previously reported in the literature. By collecting and integmeperidine 10 mg/mL). Lin et al. noted that: "The default values provided on the current interface conflict with the rating this body of evidence in the same article for the first time, the significance and implications of these findings for standard operating values used at TGH [Toronto General Hospital] . For example, the most widely used concentration patient safety become more clear. In the remainder of the article, we describe the primary novel contribution of the is 2.0 mg/mL. Users must currently toggle through four screens of default values before being able to enter this present work-an experiment comparing simulations of the commercially available and new interfaces for the LifeCare concentration. Making suitable default settings available would eliminate many of these unnecessary programming 4100 with professional nurses who already had extensive experience programming the commercially available intersteps" [26] . Accordingly, Lin et al. again used the principle of "Provide users with reliable shortcuts to increase effiface. This activity is an essential part of a comprehensive human factors engineering process [21] . The most important ciency" to redesign the interface. The initially displayed concentration value was changed to match the value that is question was whether the New interface would reduce the incidence of drug concentration programming errors. most frequently used at TGH. As a result, the first concentration value that users encounter in the programming sequence with the New interface would be more likely to be the desired value. METHOD Finally, Lin et al. conducted an experiment comparing computer simulations of the commercially available and New prototype interfaces with nursing students as particParticipants ipants. The results showed that the New prototype led to statistically significant reductions in errors, programming
Twelve recovery room nurses from TGH participated in the study. They averaged 5.15 years (SD ϭ 1.19) of clinical times, and mental workload ratings [26] .
experience with the LifeCare 4100. These nurses were on
The commercially available interface for the LifeCare 4100 can be configured to operate in several different ways a rotational schedule in which they programmed PCA pumps for 1 to 3 weeks each month. When they were on the assigned [10] . The configuration in regular use at TGH and simulated by the Old interface is the factory-set standard. In this configrotation, a nurse would program the LifeCare 4100 from 2 to 10 times per day. Institutional review board approval and uration, the pump sequentially offers four options for programming the concentration of the drug in the vial: morphine informed consent were obtained.
1 mg/mL, morphine 5 mg/mL, morphine 0.5 mg/mL, and meperidine 10 mg/mL. At each step, nurses can either accept Materials the currently displayed option and set the drug concentration, or they can reject that option and go on to the next one. If Simulations of the New prototype and commercially available interfaces running on an IBM-compatible personal comall of these are rejected, then several additional options are presented sequentially. This latter set of options can puter were used [26] . The simulation of the commercially available interface was a high-fidelity visual replica, and be selected if a drug other than morphine or meperidine is desired. will be referred to as the Old interface. Its functionality was essentially the same as that of the commercially available interface (see below). The primary difference was that the Old interface required participants to input data using a Experimental Design mouse, whereas the commercially available interface requires nurses to use touch keypads. Given these minor differ-A 2 ϫ 2 ϫ 3 ϫ 2 mixed design was adopted with Order of training (Old first and New first) as the between-participants ences, and the fact that functional fidelity plays a stronger role than physical fidelity in transfer of training for procefactor, and Interface (Old and New), Programming Task Mode (PCA, Continuous, and PCA ϩ Continuous), and dural cognitive tasks [28], the participants' extensive experience with the commercially available interface was expected Repetition (1st and 2nd) as the within-participant factors. The orders of the Interfaces and the Modes were both to generalize to the Old interface.
Both the Old and New interfaces have eight programming counterbalanced. functions. The purge function would allow users to remove air from the intravenous line before the line is connected to the patient. The concentration function specifies the numeriProcedure cal value and the units of the drug concentration (e.g., 1 mg/mL). The bolus function would allow users to administer Participants read a set of instructions on how to use one of the PCA interfaces and performed three practice tasks. a one-time infusion of analgesic (e.g., 1 mg). The mode function would allow users to choose between the three Every participant then completed a total of six different tasks (two Repetitions of each of the three Mode types). For each different modes in which the device can be operated. In the PCA mode, the device would deliver only discrete, patienttask, participants were given a TGH PCA Order Form and were asked to program the interface according to the oprequested doses of analgesic. In the Continuous mode, the device would function as a normal infusion pump (i.e., proerating values specified on the Form. The same six Order Forms were used for both interfaces. The quantitative values vide a continuous delivery of analgesic with no possibility for patient-requested doses). In the PCA ϩ Continuous of several programming parameters (e.g., drug concentration, PCA dose, continuous dose, lockout interval, and 4-h mode, the device would function in a hybrid mode with a continuous delivery of analgesic as well as the possibility limit) varied across the six Order Forms. To reduce confusion between interfaces, participants were brought in for a second for additional delivery of discrete, patient-requested doses of analgesic. The lockout interval function specifies the miniday, and were instructed and tested on the alternate interface using a comparable procedure. mum time between patient-administered doses (e.g., 5 min). The 4 h limit function specifies the maximum amount of analgesic that could be delivered during any 4-h period (e.g., 30 mg). The PCA dose function specifies the amount of Dependent Variables analgesic that would be delivered for each patient-requested dose (e.g., 1 mg). The continuous dose function specifies
There is only one correct action sequence for each programming task, so an error was defined as any deviation from the amount of analgesic that would be continuously delivered per unit time (e.g., 1 mg/h).
this gold standard, regardless of whether it was subsequently workload ratings were collected after each trial using the NASA-TLX rating scale [29] . This scale is a sensitive and Fig. 3 . The New interface was faster than the Old (F(1, 10) ϭ 12.17, P ϭ 0.006). Also, the second mands, Physical Demands, Temporal Demands, Own Performance, Effort, and Frustration). The participants' ratings on repetition was faster than the first (F(1, 10) ϭ 21.81, P ϭ 0.001). In addition, the Modes differed, the PCA ϩ Continuthese individual subscales are then combined to obtain an overall workload rating for each participant for each trial.
ous Mode being the slowest and the PCA Mode being the fastest (F(2, 20) ϭ 5.4, P ϭ 0.013). Finally, there was an At the end of the experiment, participants were debriefed and their subjective preferences and qualitative comments interaction between Repetition and Mode (F(2, 20) ϭ 5.64, P ϭ 0.011). The reduction in time with Repetition was were both recorded.
smaller in the PCA Mode than in the other two Modes, probably because the nurses had the most experience with Data Analysis programming that Mode in clinical practice. The statistically significant effects for mental workload Errors and the subjective preference ratings were analyzed are shown in Fig. 4 . Workload was lower for the second using 2 tests, except when there was a small number of repetition than for the first (F(1, 10) ϭ 6.27, P ϭ 0.03). observations, in which case a binomial test was used instead.
Also, there was a Repetition ϫ Mode ϫ Interface interaction Task completion time and workload ratings were analyzed (F(2, 20) ϭ 8.62, P ϭ 0.002). The percentage reduction in using a mixed analysis of variance. All statistical tests that workload with Repetition was larger with the New interface were significant at a level of P Ͻ 0.05 are reported. No than with the Old for the Continuous and PCA ϩ Continuous other tests reached statistical significance.
Modes. Participants seemed to find it progressively easier to program the two less familiar Modes with the New interface than with the Old.
RESULTS
Nine nurses favored the New interface and one preferred the Old ( 2 (1) ϭ 6.4, P Ͻ 0.02). Two nurses expressed no preference. The qualitative comments provided by partic- Table 1 summarizes the error data. In total, more errors were made with the Old interface than with the New ipants for the Old interface describe some of the problems that participants experienced initially in learning how to use ( 2 (1) ϭ 6.1, P Ͻ 0.02). Also, more errors were made in programming the mode function with the Old interface than the commercially available device in a clinical setting, the positive impact of frequency of use on ease of programming, with the New ( 2 (1) ϭ 4.6, P Ͻ 0.05). Most importantly of all, no drug concentration errors were made with the New and the importance of involving representative users in the design process. The comments for the New interface are interface, whereas eight such errors were made with the Old (binomial test, P Ͻ 0.008). Three of these errors were not generally more positive and consistent with the objective performance results, although there was one suggestion for detected and left uncorrected.
The statistically significant effects for task completion how to improve the design of the bolus function. 
DISCUSSION
4100 eliminated drug concentration errors, whereas eight such errors were observed with the Old interface, three of which were uncorrected. This finding should be treated with This experiment appears to be the first to evaluate the caution due to the low number of observations per particimpact of a human factors engineering process on the redeipant. Nevertheless, it is worth noting that the concentration sign of a commercially available medical device with experienced users. The New prototype interface for the LifeCare errors were eliminated with the New prototype despite the fact that the nurses had only minimal exposure with this and was preferred by a strong majority of nurses. There was interface, but averaged over 5 years of experience with the no significant difference in mental workload ratings between commercially available interface. This result shows that interfaces. The subjective comments obtained from the parpresenting a new design to users who have extensive experiticipants generally favored the New interface, and thus were ence with an old design for the same device need not "cause in agreement with the objective performance data. For exama huge increase in errors that result from users exercising ple, one participant stated that the New interface was simple, an over-learned, previously appropriate, response" [30] .
user friendly, and easier to learn to use than the Old interface. In a clinical setting, the three uncorrected concentration These subjective comments, and the observed reductions in errors could have resulted in repeated overdeliveries of analprogramming errors and times, confirm the informal impresgesic to patients. For example, one participant mistakenly sion created by Fig. 2 that the New interface is simpler to accepted the initially displayed concentration value of 1 mg/ program than the Old. mL when the desired concentration value was 2 mg/mL. In When combined with our earlier work, these results show a clinical setting, this error could have resulted in a twofold the value of following a comprehensive human factors engioverdelivery of morphine every time a dose was delivered neering process as opposed to only relying on human factors to the patient. Recall that the programmed concentration design principles alone. Lin et al. were unaware of any value is used to calculate when the 4-h limit should be patient injuries and deaths with the LifeCare 4100, so they invoked. Thus, this same concentration error could also have could not have based the New design on adverse drug event allowed 60 mg, rather than the intended limit of 30 mg, to reports [26] . Furthermore, they had not conducted an experibe infused over any 4-h period, thereby relaxing one of the ment with professional nurses. Nevertheless, as mentioned safety features of the device. Adverse event reports have earlier, Lin et al. redesigned the LifeCare 4100 interface so repeatedly stated that concentration programming errors are that the initially displayed concentration is a high, rather an important potential threat to patient safety in PCA pump than a low, value because the higher concentration value usage [9] [10] [11] [12] [13] [14] .
The New interface also led to faster completion times, was more frequently used in clinical practice.
Reviews of adverse events and experiments with represen-CONCLUSIONS tative users are essential parts of a human factors engineering system design process [21] . In this research, these two activiAdverse drug events are the leading threat to patient safety. ties uncovered new safety-relevant evidence that had not This research showed that, by redesigning a commercially been identified using design guidelines alone. This new eviavailable PCA pump interface using a human factors engidence did not point to a need to change the prototype created neering process, drug concentration errors and task compleby Lin et al. because the initially displayed concentration tion times were both reduced for experienced users under value had already been changed for reasons of efficiency.
laboratory conditions. The generalizability of these findings However, in other cases, new information identified by reto other PCA pump interfaces, to other drug delivery devices, views of adverse events or testing with representative users and to other medical products or systems can only be definimay identify a need to make further design changes to the tively established with more empirical research. However, interface [31] .
the success of human factors engineering in improving safety This research has limitations that suggest future research in other domains, such as aviation and nuclear power, sugtopics. First, the participants were recovery room nurses gests that the benefits of this approach are likely to generalize who program PCA pumps up to 10 times a day. Floor nurses widely [20] . also sometimes program PCA pumps, but typically far less
To take just two biomedical informatics-related examples, frequently. Thus, it would be useful to replicate this experiprevious human factors engineering research has shown that ment with floor nurses as participants. Given the particboth an interface for a computer-based patient-monitoring ipants' qualitative comments regarding the importance of system for use in cardiac anesthesia and an interface for a frequency of use on ease of programming with the commercomputer-based infusion device for terbutaline therapy to cially available design, the impact of interface redesign may treat preterm labor suffer from unnecessarily complex diabe even greater than that observed here. Second, nurses are logue structures that cause difficulties for device users [32, frequently interrupted when they program PCA pumps in 33]. The research presented here goes two steps further clinical practice, but they were not interrupted in this experiby showing how these limitations might be systematically ment. The impact of interruptions should be investigated.
addressed by device redesign, and by suggesting that such The benefits of the New interface may be even greater under changes may result in safety and efficiency improvements. such conditions because it provides more feedback than the If these predictions are confirmed, then human factors Old. If nurses do not have to rely as much on memory, then engineering may have important implications for the design, they may be able to see, rather than remember, in what regulation, and procurement of biomedical devices, prodstate they left the device after an interruption. Third, both ucts, or systems. Medical manufacturers might enhance pasimulated interfaces used a mouse for data input, whereas tient safety by adopting a human factors engineering process the commercially available device uses a keypad. More rein the design of their products. Government medical regulasearch is required to determine how the absolute level of tors might enhance patient safety by putting a greater emphaperformance would change if a keypad were used. Note, sis on human factors engineering design criteria when makhowever, that the primary focus of this research was not the ing product approval and regulation decisions. Finally, absolute level of performance of either interface, but rather hospital risk managers and procurement staff might enhance the relative level of performance between interfaces. Therepatient safety by adopting human factors engineering fore, the difference in input modality is not of great concern criteria-particularly user testing and evaluation-before for our purposes because there is no reason to believe that making product purchasing decisions. using a mouse would affect one interface more than the other, particularly since Interface was a within-participants factor. Because both interfaces required all participants to use a mouse instead of a keypad, the safety and efficiency ACKNOWLEDGMENTS benefits of the New interface cannot be attributed to the input modality. Fourth, the experiment was conducted in a laboratory rather than in a field setting. Clinical trials must 
